Phenylephrine Hydrochloride
Total Payments
$388,249
Transactions
100
Doctors
1
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $33,627 | 13 | 0 |
| 2023 | $45,490 | 14 | 0 |
| 2022 | $118,014 | 9 | 0 |
| 2021 | $18,750 | 12 | 0 |
| 2020 | $30,796 | 12 | 1 |
| 2019 | $26,261 | 13 | 1 |
| 2018 | $115,312 | 27 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $379,475 | 96 | 97.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,622 | 3 | 2.0% |
| Consulting Fee | $1,152 | 1 | 0.3% |
Payments by Type
Research
$379,475
96 transactions
General
$8,774
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Phase 4 Open Label Pediatric Study to Determine Pharmacokinetics of Phenylephrine | Hikma Pharmaceuticals USA | $264,163 | 1 |
| Phase 4 Open Label Pediatric Study to Determine Pharmacokinetics of Phenylephrine | West-Ward Pharmaceuticals | $115,312 | 0 |
Top Doctors Receiving Payments for Phenylephrine Hydrochloride
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Washington, DC | $385,977 | 98 |
| , M.D | Anesthesiology | Scottsdale, AZ | $2,272 | 2 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $272,937
- West-Ward Pharmaceuticals $115,312
Product Information
- Type Drug
- Total Payments $388,249
- Total Doctors 1
- Transactions 100
About Phenylephrine Hydrochloride
Phenylephrine Hydrochloride is a drug associated with $388,249 in payments to 1 healthcare providers, recorded across 100 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2018 to 2024. In 2024, $33,627 was paid across 13 transactions to 0 doctors.
The most common payment nature for Phenylephrine Hydrochloride is "Unspecified" ($379,475, 97.7% of total).
Phenylephrine Hydrochloride is associated with 2 research studies, including "Phase 4 Open Label Pediatric Study to Determine Pharmacokinetics of Phenylephrine" ($264,163).